Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01−0.13 (-11.40%)
Close on Nov 16, 2026Market cap $9.55MP/E –Yield –
Cellectar Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for Cellectar Biosciences
Cellectar Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?